Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,109 | 2,004 | 5,000 | 4,510 | 5,593 |
| Marketable Securities | 2,005 | N/A | N/A | 4,520 | 6,000 |
| Other current assets | 1,013 | 972 | 1,016 | 483 | 652 |
| TOTAL | $5,170 | $3,028 | $6,128 | $9,580 | $12,347 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 3 | 5 | 5 |
| Intangibles | 2,460 | 34 | 43 | 53 | 66 |
| Other Non-Current Assets | 0 | 1 | 0 | 0 | 0 |
| TOTAL | $2,460 | $35 | $46 | $58 | $71 |
| Total Assets | $7,630 | $3,062 | $6,174 | $9,638 | $12,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106 | 330 | 402 | 66 | 408 |
| TOTAL | $1,662 | $723 | $833 | $411 | $607 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -1 | -2 | 0 | 0 | 0 |
| TOTAL | $-1 | $-2 | $0 | $0 | $0 |
| Total Liabilities | $1,661 | $721 | $833 | $411 | $607 |
| Shareholders' Equity | |||||
| Common Shares | 5,324 | 687 | 687 | 687 | 687 |
| Retained earnings | -30,432 | -28,918 | -25,792 | -21,887 | -19,172 |
| Other shareholders' equity | 2,382 | 2,702 | 2,576 | 2,557 | 2,426 |
| TOTAL | $5,969 | $2,341 | $5,341 | $9,227 | $11,811 |
| Total Liabilities And Equity | $7,630 | $3,062 | $6,174 | $9,638 | $12,418 |